This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:


peer-reviewed publication

trusted source


Antimicrobial nanonets display multifunctionality by mitigating inflammatory responses during sepsis

Antimicrobial nanonets display multifunctionality by mitigating inflammatory responses during sepsis
Schematic illustrates the proposed anti-inflammatory mechanisms of the fibrillating peptides: (1) Endotoxin trapping by the nanonets; (2) Cytokine trapping by the nanonets; and (3) Intracellular effect by soluble peptide molecules. Credit: Advanced Healthcare Materials (2023). DOI: 10.1002/adhm.202203232

National University of Singapore (NUS) pharmaceutical scientists have developed multi-functional synthetic peptide nanonets for relieving inflammation caused by bacterial infection. This is achieved by concurrent trapping of bacterial endotoxins and pro-inflammatory cytokines.

Endotoxemia is characterized by the presence of endotoxins in the blood. These endotoxins can be released by such as E. coli during systemic infections. When left unchecked, inflammatory host responses can result in extensive tissue damage and , which are associated with a . Unfortunately, past research efforts to develop targeted therapies against sepsis have largely been unsuccessful due to the complex nature of interactions between pro- and anti-inflammatory mediators.

A more recent approach focuses on multi-cytokine for better management of septic complications. A research team led by Associate Professor Rachel Ee from the Department of Pharmacy, NUS demonstrated that antibacterial peptide nanonets could possess additional functionalities to mitigate that are commonly associated with bacterial infections.

These findings are built on the team's previous report of the design of anti-microbial peptides capable of in situ self-assembly into bacteria-trapping nanonets. Anti-inflammatory activity was achieved through the ability of the nanonets to bind and entrap endotoxins released by gram-negative pathogens, and inflammation mediators produced by host macrophages. Of interest, the cationic nanonets selectively entrapped pro-inflammatory cytokines while minimally binding the anti-inflammatory cytokines. The team achieved this desirable specificity by capitalizing on the overall difference in net charge between these two different groups of cytokines.

The new study is published in the journal Advanced Healthcare Materials.

Additionally, the lipopolysaccharide (LPS)-binding effect resulted in the restoration of antimicrobial activity of colistin, a last-line therapy, against gram-negative pathogens. Notably, this is the first reported instance of multi-functional peptide nanonets with long-ranging effects in alleviating the damages of septic complications at multiple stages. Biological evaluations of the peptide nanonets using an acute lung injury model demonstrated their efficacy in lowering the level of in the bronchoalveolar fluid of endotoxin-inoculated murine models. The resulting peptide effect was comparable to the control drug dexamethasone.

Prof. Ee said, "Our peptide-based nanonets have shown unique therapeutic potential as a multi-functional biomaterial for holistic management of sepsis. Moving forward, we hope to continue their optimization for clinical use."

More information: Nhan Dai Thien Tram et al, Multifunctional Antibacterial Nanonets Attenuate Inflammatory Responses through Selective Trapping of Endotoxins and ProÔÇÉInflammatory Cytokines, Advanced Healthcare Materials (2023). DOI: 10.1002/adhm.202203232

Journal information: Advanced Healthcare Materials

Citation: Antimicrobial nanonets display multifunctionality by mitigating inflammatory responses during sepsis (2023, May 22) retrieved 7 June 2023 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Trapping and killing superbugs with novel peptide 'nanonets'


Feedback to editors